Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B05BC01	MANNITOL	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	613,662 L.L
B05BC01	MANNITOL 20% INJECTION USP	G	Mannitol - 20%	20%	Injectable solution	374,633 L.L
R05CB06	MUCOVIC FORTE	G	Ambroxol HCl - 30mg/5ml	30mg/5ml	Solution, sugar free	293,086 L.L
B05BC01	MANNITOL 20% INJECTION USP	G	Mannitol - 20%	20%	Injectable solution	613,662 L.L
M05BA07	MADRONATE	G	Risedronate sodium - 35mg	35mg	Tablet, film coated	724,907 L.L
R05CB06	MUCOVIC FORTE	G	Ambroxol HCl - 30mg/5ml	30mg/5ml	Solution, sugar free	440,268 L.L
B05BC01	MANNITOL 20% INJECTION USP	G	Mannitol - 20%	20%	Injectable solution	344,754 L.L
R05CB06	MUKORAL	G	Ambroxol HCl - 30mg/5ml	30mg/5ml	Syrup	341,336 L.L
B05BC01	MANNITOL 20% INJECTION, USP	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	402,213 L.L
L04AX07	MAROVAREX	G	Dimethyl Fumarate - 120mg	120mg	Capsule, hard, gastro-resistant	9,838,676 L.L
R05CB06	MUKORAL	G	Ambroxol - 30mg	30mg	Tablet	201,576 L.L
B05BC01	MANNITOL 20% INJECTION, USP	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	402,213 L.L
L04AX07	MAROVAREX	G	Dimethyl Fumarate - 240mg		Capsule, hard, gastro-resistant	60,848,734 L.L
B05BC01	MANNITOL	G	Mannitol - 10g/100ml	10g/100ml	Injectable solution	329,815 L.L
L01DB07	MITOXANTRON EBEWE	G	Mitoxantrone - 20mg/10ml	20mg/10ml	Injectable concentrated solution	11,064,120 L.L
B05BC01	MANNITOL	G	Mannitol - 10g/100ml	10g/100ml	Injectable solution	494,147 L.L
B05BC01	MANNITOL 10% USP INJECTION	G	Mannitol - 10%	10%	Injectable solution	430,943 L.L
P01AB01	METROLAG	G	Metronidazole benzoate - 125mg/5ml	125mg/5ml	Syrup	391,634 L.L
B05BC01	MANNITOL 10% USP INJECTION	G	Mannitol - 10%	10%	Injectable solution	326,367 L.L
P01AB01	METROLE	G	Metronidazole benzoate - 125mg/5ml	125mg/5ml	Syrup	391,634 L.L
S03CA04	MYCICORT	G	Hydrocortisone acetate - 5mg, Neomycin sulfate - 5mg		Drops suspension	166,381 L.L

...